Enfiera 500mg injection | Rituximab | MHP (1)

1
Enfiera 500mg injection Rituximab MHP

• MILLION HEALTH PHARMACEUTICALS

2
DESCRIPTION

• Enfiera 500mg is an anticancer medicine which
  prevents the growth and spread of cancer cells in
  the body.
•  Enfiera 500mg injection also indicated for the
  treatment of Non- Hodgkins lymphoma or chronic
  lymphocytic and with combination with another
  anticancer drugs like methotrexate is used for
  rheumatoid arthritis symptoms in adult treatment. 

3
INDICATION

• Enfiera 500mg and hyaluronidase human injection
  are given alone or combination with other drugs
  to treat certain types of non-Hodgkin's lymphoma
  and chronic lymphocytic leukemia (cancer start in
  WBC).
• Enfiera 500mg injection is also used with
  methotrexate (Otrexup, Rasuvo, Xatmep, others)
  for the treatment rheumatoid arthritis symptoms
  in adults that have been already treated with
  some type of regimen known as tumor necrosis
  factor (TNF) inhibitor. 

4
INDICATION

• NON HODGKINS LYMPHOMA

• CHRONIC LYMPHOCYTIC LEUKEMIA

5
MECHANISM OF ACTION

• Enfiera 500mg injection is a type of class called
  as monoclonal antibody and which is a new type of
  "targeted" cancer treatment and an integral part
  of the body's immune system.
• Enfiera 500mg works by linking to the CD20
  antigen on normal and malignant B-cells. Hence
  the body's essential immune security is initiated
  to attack and kill the marked B-cells

6
PRODUCT DETAILS

• Brand Enfiera
• Ingredients Rituximab 
• Strength 500mg 
• Manufactured Biochem Pharmaceuticals
  Industries
• Package
• 50ml in a 1vial

7
PHARMACOKINETICS

• ABSORPTIONNot availableDISTRIBUTIONvolume
  of distribution is 3.1 LMETABOLISMEnfiera
  500mg injection metabolized by human antimurine
  antibody production.EXCRETIONnot
  availableThe half-life of NHL is 22 days and for
  RA is 18.0 days, GPA and microscopic polyangiitis
  is 23 days

8
DOSAGE MANAGEMENT

• Enfiera 500mg is recommended to administer only
  through intravenous infusion not by IV push or
  bolus.
• ADMINISTRTION
• Take an Enfiera 100mg amount and diluted to final
  concentration of 1 mg/ml up to 4 mg/ml as
  infusion (containing either 0.9 Nacl or 5
  dextrose in water). Invert gently the bag and mix
  the solution. Dispose unused drug left in vial.

9
PRECAUTIONS

• Allergic condition against Enfiera 500mg
  injection or any other medication informs your
  doctor.
• Avoid use of Enfiera 500mg injection if you are
  pregnant. It will harm the baby unborn, while
  using Enfiera 100mg use correct birth control to
  prevent pregnancy and for at least 2 weeks after
  your treatment ends.
• It is unknown whether Enfiera 500mg passes into
  breast milk, avoid breast-feed while on Enfiera
  500mg treatment.

10
SIDE EFFECTS

• Common effectsfever and chills (flu like
  symptoms)
• Less common side effects
• Weakness
• nausea
• headache
• cough
• dyspnea
• pharyngitis

11
DRUG INTERACTION

• Enfiera 500mg drug interaction has limited data
  is available at present.Combination with
  fludarabine or cyclophosphamide has no effects in
  pharmacokinetics in CLL patients.Combination
  with methotrexate had no effects in
  pharmacokinetics.

12
CONTRAINDICATIONS

• Hypersensitivity or murine proteins.Active
  severe infections in rheumatoid
  arthritisUncontrolled cardiac disease.

13
PREGNANCY

• Category C animal studies reproduction shown an
  adverse effect on the fetus.
• The drug has no enough and well controlled
  studies in humans, using in pregnant women
  benefits by warrant use of the drug.

14
LACTATION

• Enfiera 500mg injection excreted into human milk
  is unknown. Due to the drug belongs to large
  protein molecule, no information is available.
  Women should not breast feed during Enfiera 500mg
  treatment and 12 months following last dose.

15
STORAGE 

• Store at 20C 30C Use the drug before
  expiry date Protected from direct sunlight Do
  not freeze or shake. Keep away from the
  childrens Discard the unused drug by asking
  the advice from doctor or pharmacist.

16
MISSED DOSE

• If a dose missed to take at the time then have it
  suddenly before next dose timing, if time reach
  for next dose, then skip missed dose and continue
  and continue the regular schedule. Do not have 2
  doses at a same time.

17
OVERDOSAGE

• If the patients had high dose of Enfiera
  500mg then seek immediately to the emergency
  department or poison control help line. Please
  consult the doctor for further clarification.

18
CONTACT US

• EMAILID millionhealthpharmaceuticals_at_gmail.com
• PHONE NO 
• 91-9940472902
• WEBSITE URL https//millionpharma.com/enfiera-500
  mg.php

19
(No Transcript)